Why Trauma Screening Matters
Chronic stress and unresolved trauma do more than affect the mind—they disrupt the body at a cellular level, triggering conditions like anxiety, depression, autoimmune disorders, and inflammation-driven diseases. By detecting these impacts early, you can intervene before long-term damage occurs, improving outcomes for your patients and reducing healthcare costs.
Understanding Trauma’s Impact
A Game Changer
for Mental Health
Legitimize the Medical Realities of Trauma
Our TAI™ Screening is a valuable tool that enhances your current practice by helping mental health practitioners identify whether a patient has experienced trauma. This understanding is crucial for developing personalized treatment plans and effectively addressing the intricate nature of trauma in a way that resonates with patients, providers, and policymakers.
How TAI™ Screening Supports Your Practice
Our Trauma Autoimmune Indicator™(TAI) test integrates effortlessly into your existing clinical workflows, providing:
A Baseline for Health
Use TAI™ screening to establish a starting point for treatment and monitor progress over time
Early Intervention Opportunities
Prevent costly treatments by addressing trauma-related conditions before symptoms worsen
Objective, Actionable Data
Move beyond self-reporting with measurable insights that guide precise care
Relapse Prevention
Detect early signs of recurrence to intervene promptly and help prevent setbacks
The Science Behind
TAI™ Screening
iXpressGenes’ TAI™ screening uses advanced RNA dysregulation to detect early molecular changes from trauma and chronic stress. By identifying key immune protein dysregulations, TAI™ testing empowers practices to offer proactive, science-based trauma care, keeping patients healthier and preventing long-term damage.
RNA Biomarkers at Work
